SOD1 and amyotrophic lateral sclerosis: Here, we demonstrate using an in vitro cell model of SOD1-associated ALS that CuATSM, ebselen and telbivudine (CET) polytherapy improves cell survival, decreases SOD1 inclusion formation and improves SOD1 folding compared to CuATSM alone.